| Schedule of recognized identified assets acquired and liabilities assumed |
The purchase price amount related to the Merger has been allocated to the related assets acquired and liabilities assumed based upon their respective fair values as follows: | | | | | Cash consideration | $ | 298,857 |
| Acquisition consideration payable | 16,768 |
| Fair value of non-controlling interests | 395,663 |
| Fair value of Symbion | 711,288 |
| Net assets acquired: | | Cash | 40,374 |
| Accounts receivable, net | 79,830 |
| Inventories | 18,389 |
| Prepaid expenses and other current assets | 9,876 |
| Property and equipment | 153,179 |
| Investments in and advances to affiliates | 32,728 |
| Intangible assets | 31,534 |
| Restricted invested assets | 316 |
| Other long-term assets | 6,239 |
| Accounts payable | (20,419 | ) | Accrued payroll and benefits | (14,600 | ) | Other current liabilities | (47,229 | ) | Current maturities of long-term debt | (83,805 | ) | Long-term debt, less current maturities | (376,395 | ) | Long-term deferred tax liabilities | (19,853 | ) | Other long-term liabilities | (60,500 | ) | Net assets acquired | (250,336 | ) | Excess of fair value over identifiable net assets acquired | $ | 961,624 |
|
The aggregate amounts preliminarily recognized as of the acquisition date for each major class of assets and liabilities assumed in the acquisitions closed during the year ended December 31, 2016 are as follows: | | | | | Cash consideration | $ | 135,061 |
| Fair value of non-controlling interests | 27,164 |
| Aggregate fair value of acquisitions | 162,225 |
| Net assets acquired: | | Cash and cash equivalents | 4,855 |
| Accounts receivable | 6,291 |
| Other current assets | 517 |
| Property and equipment | 3,921 |
| Intangible assets | 4,475 |
| Long-term assets | 56 |
| Accounts payable and other current assets | (1,490 | ) | Current maturities of long-term debt | (3,926 | ) | Long-term deferred tax liability | (172 | ) | Long-term liabilities | (197 | ) | Net assets acquired | 14,330 |
| Excess of fair value over identifiable net assets acquired | $ | 147,895 |
|
|
| Schedule of unaudited consolidated pro forma results |
The unaudited consolidated pro forma results for years ended ended December 31, 2014 and 2013, assuming the Symbion acquisition had been consummated on January 1, 2013, are as follows (in thousands): | | | | | | | | | | Year Ended December 31, | | 2014 | | 2013 | Net revenues | $ | 873,683 |
| | $ | 820,186 |
| | | | | Net income | 31,557 |
| | 42,714 |
| Less: net income attributable to non-controlling interests | (68,973 | ) | | (64,396 | ) | Net loss attributable to Surgery Partners, Inc. | $ | (37,416 | ) | | $ | (21,682 | ) |
|